Welcome to the European Neuroendocrine Tumor Society

Founded in 2004, ENETS is the leading and longest-established society dedicated to improving the diagnosis and treatment of neuroendocrine tumours (NETs). It has over 1,500 members from various medical disciplines, including oncology, endocrinology, gastroenterology, nuclear medicine, pathology, radiology, surgery, and basic/translational science.

Our mission is to raise awareness, advance research, and foster collaboration in the NET field.

ENETS provides accredited educational programmes, including conferences, webinars, and e-learning – designed by experts for healthcare professionals. Our vibrant, multidisciplinary community extends well beyond Europe, united in the goal of improving NET diagnosis, treatment, and care.

Upcoming Webinar

Join us for next week's joint ENETS-INCA NET Cancer Day Educational Webinar 2025!

When: Wed 12 Nov at 16:00 CET
Where: live on Zoom

Learn more & register

ENETS Newsletters

All newsletters

ENETS Grants 2025

Applications are still open for two ENETS grants:

  • ENETS Travel Grant 2026
  • ENETS DB Grant for Level II and III Studies.

Don't let these opportunities pass you by!

Learn more and apply now!

ENETS Publications

New ENETS Guidance Paper

We are pleased to announce the release of the latest ENETS guidance paper in the Journal of Neuroendocrinology:

Title: European Neuroendocrine Tumor Society (ENETS) 2024 Guidance Paper for the Management of Well-Differentiated Small Intestine Neuroendocrine Tumours

This is the eighth new publication on neuroendocrine tumour management featured in the Journal of Neuroendocrinology.

ENETS Members: Access this paper and other NET-related articles for free through your myENETS account.

Discover all ENETS guidelines

SurvivApp Study

ENETS is proud to announce the publication of the ENETS-endorsed SurvivApp study, titled “Hemicolectomy versus Appendectomy for Patients with Appendiceal Neuroendocrine Tumours 1–2 cm in Size: A Retrospective, Europe-wide, Pooled Cohort Study” in Lancet Oncology.

We congratulate and thank everyone involved in this important research and are delighted to have supported this significant initiative.

Read the article at The Lancet Oncolody

Basic & Translational Science Task Force Whitepaper

ENETS is excited to announce the publication of the basic and translational science task force whitepaper: White paper on best practices for translational research in neuroendocrine neoplasms

Published in the Journal of Neuroendocrinology on 28 July 2025.

Read JNE article

MEN1 Task Force Study

ENETS is excited to announce the publication of its MEN1 Task Force study: Screening and surveillance practices for Multiple Endocrine Neoplasia type 1-related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence (ENETS CoE) — An ENETS MEN1 task force questionnaire study.

Published in the Journal of Neuroendocrinology on 26 November 2024.

Read JNE article

NENs Policy Recommendations

At the 2024 ENETS Annual Conference, we hosted a groundbreaking roundtable discussion on the barriers to accessing high-quality care for Neuroendocrine Neoplasms (NENs) across Europe. The discussion brought together physicians, patients, and EU policymakers and aligned with the ENETS-endorsed publication from 2023.

ENETS extends its gratitude to all those who contributed to this important paper and participated in the roundtable. We are proud to have supported this significant initiative.

Read the policy recommendations

Membership matters

Multidisciplinary is our credo. We welcome all NET-related disciplines and professionals! Learn more about the benefits of becoming an ENETS member.

Learn more

Support ENETS

Any donation made to ENETS charity, no matter what size, will help to support us with our many projects. ENETS wants to ensure that neuroendocrine cancer patients in Europe get a timely diagnosis, the best level of care and ultimately, a cure. Click below to read more.

Donate now

ENETS FACTS

22 Annual Conferences
Since 2004
3 Hybrid conferences from 2022 - 2024
5 Virtual conferences
between 2020 - 2024
1,610 Currently registered members